{"url_path":"/sec/byah/10-k/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"20-F/A","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1986247/0001213900-26-057152-index.html","accession_number":"0001213900-26-057152","cik":"0001986247","ticker":"BYAH","issuer_name":"Park Ha Biological Technology Co., Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1986247/0001213900-26-057152-index.html","primary_entity_key":"0001986247","primary_entity_name":"Park Ha Biological Technology Co., Ltd."},"word_count":872,"has_tables":true,"body_markdown":"**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**Washington,\nD.C. 20549**\n\n \n\n**FORM 20-F/A**\n\n**(Amendment No. 2)**\n\n \n\n**(Mark\nOne)**\n\n \n\n☐ **REGISTRATION\nSTATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**OR**\n\n \n\n☒ **ANNUAL\nREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nFor\nthe fiscal year ended October 31, 2025\n\n \n\n**OR**\n\n \n\n☐ **TRANSITION\nREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**OR**\n\n \n\n☐\n**SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nDate\nof event requiring this shell company report\n\n \n\nFor\nthe transition period from ____________ to ____________\n\n \n\nCommission\nfile number: 001-42453\n\n \n\n**Park\nHa Biological Technology Co., Ltd.**\n\n(Exact\nname of registrant as specified in its charter)\n\n \n\n**N/A**\n\n(Translation\nof Registrant’s name into English)\n\n \n\n**Cayman\nIslands**\n\n(Jurisdiction\nof incorporation or organization)\n\n \n\n**901,\nBuilding C**\n\n**Phase\n2, Wuxi International Life Science Innovation Campus**\n\n**196\nJinghui East Road**\n\n**Xinwu\nDistrict, Wuxi, Jiangsu Province**\n\n**People’s\nRepublic of China 214000**\n\n(Address\nof principal executive offices)\n\n \n\n**Xiaoqiu\nZhang, Chief Executive Officer**\n\n**Tel.:\n+86 400 012 7562**\n\n**Email:\nir@parkha.cn**\n\n**901,\nBuilding C**\n\n**Phase\n2, Wuxi International Life Science Innovation Campus**\n\n**196\nJinghui East Road**\n\n**Xinwu\nDistrict, Wuxi, Jiangsu Province**\n\n**People’s\nRepublic of China 214000**\n\n(Name,\nTelephone, E-mail and/or Facsimile number and Address of Company Contact Person)\n\n \n\nSecurities\nregistered or to be registered pursuant to Section 12(b) of the Act.\n\n \n\n**Title of each class**   **Trading Symbol(s)**   **Name of each exchange on which registered**\n\nOrdinary Shares, par value\n$0.001 per share   BYAH  \nThe Nasdaq Stock Market LLC\n\n(Nasdaq Capital Market)\n\n \n\nSecurities\nregistered or to be registered pursuant to Section 12(g) of the Act.\n\n \n\n**None**\n\n(Title\nof Class)\n\n \n\nSecurities\nfor which there is a reporting obligation pursuant to Section 15(d) of the Act.\n\n \n\n**None**\n\n(Title\nof Class)\n\n \n\nIndicate\nthe number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered\nby the annual report.\n\n \n\nAs\nof October 31, 2025, there were 296,488 Class A ordinary shares issued and 381,000 Class B ordinary shares issued and outstanding.\n\n \n\n \n\nIndicate\nby check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.\n\n \n\n☐\nYes ☒ No\n\n \n\nIf\nthis report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section\n13 or 15(d) of the Securities Exchange Act of 1934.\n\n \n\n☐\nYes ☒ No\n\n \n\nIndicate\nby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange\nAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)\nhas been subject to such filing requirements for the past 90 days.\n\n \n\n☒\nYes ☐ No\n\n \n\nIndicate\nby check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data\nFile required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding\n12 months (or for such shorter period that the registrant was required to submit and post such files).\n\n \n\n☒\nYes ☐ No\n\n \n\nIndicate\nby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth\ncompany. See the definitions of “large accelerated filer,” “accelerated filer,” and “emerging growth company”\nin Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer ☒\n\n        Emerging growth company ☒\n\n \n\nIf\nan emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided\npursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\n†The\nterm “new or revised financial accounting standard” refers to any update issued\nby the Financial Accounting Standards Board to its Accounting Standards Codification after\nApril 5, 2012.\n\n \n\nIndicate\nby check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness\nof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered\npublic accounting firm that prepared or issued its audit report. ☐\n\n \n\nIf\nsecurities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant\nincluded in the filing reflect the correction of an error to previously issued financial statements. ☐\n\n \n\nIndicate\nby check mark whether any of those error corrections are restatements that required a recovery analysis of incentive based compensation\nreceived by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐\n\n \n\nIndicate\nby check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:\n\n \n\nU.S. GAAP ☒ International Financial Reporting Standards as issued by the\nInternational Accounting Standards Board ☐ Other ☐\n\n \n\nIf\n“Other” has been checked in response to the previous question, indicate by check mark which financial statement item the\nregistrant has elected to follow.\n\n \n\n☐"}